Annual Results Results Snapshot
Figures in Cr
Standalone - Balance Sheet Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Balance Sheet Analysis Highlights
Borrowings
No Borrowings in the last few periods;
Other Long Term Liabilities
YoY Growth in year ended Mar 2026 is 208.63% vs 1,283.09% in Mar 2025
Fixed Assets
YoY Growth in year ended Mar 2026 is -83.64% vs -54.52% in Mar 2025
Investments
No Investments in the last few periods;
Current Assets
YoY Growth in year ended Mar 2026 is 29.62% vs 43.92% in Mar 2025
Compare Balance Sheet Results of Astrazeneca Phar
Figures in Cr
Standalone - Balance Sheet Results
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
5.00
24.55
-19.55
-79.63%
Share Warrants & Outstandings
Total Reserve
867.79
3,300.34
-2,432.55
-73.71%
Shareholder's Funds
872.79
3,332.13
-2,459.34
-73.81%
Minority Interest
0.00
0.00
0.00
0.00%
Long-Term Borrowings
0.00
0.00
0.00
0.00%
Secured Loans
0.00
0.00
0.00
0.00%
Unsecured Loans
0.00
0.00
0.00
0.00%
Deferred Tax Assets / Liabilities
-37.80
57.79
-95.59
-165.41%
Other Long Term Liabilities
118.67
48.79
69.88
143.23%
Long Term Trade Payables
0.00
0.00
0.00
0.00%
Long Term Provisions
15.83
36.15
-20.32
-56.21%
Total Non-Current Liabilities
96.70
142.73
-46.03
-32.25%
Current Liabilities
Trade Payables
782.70
372.37
410.33
110.19%
Other Current Liabilities
143.19
105.76
37.43
35.39%
Short Term Borrowings
0.00
0.00
0.00
0.00%
Short Term Provisions
55.92
29.91
26.01
86.96%
Total Current Liabilities
981.81
508.04
473.77
93.25%
Total Liabilities
1,951.30
3,982.90
-2,031.60
-51.01%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
41.46
1,366.62
-1,325.16
-96.97%
Less: Accumulated Depreciation
36.79
329.07
-292.28
-88.82%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
4.67
1,037.55
-1,032.88
-99.55%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
0.00
273.40
-273.40
-100.00%
Intangible assets under development
0.00
10.35
-10.35
-100.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
0.00
0.08
-0.08
-100.00%
Long Term Loans & Advances
93.90
12.16
81.74
672.20%
Other Non Current Assets
0.00
0.00
0.00
0.00%
Total Non-Current Assets
211.37
1,333.54
-1,122.17
-84.15%
Current Assets Loans & Advances
Current Investments
0.00
780.38
-780.38
-100.00%
Inventories
1,027.33
691.93
335.40
48.47%
Sundry Debtors
213.68
1,072.96
-859.28
-80.08%
Cash and Bank
448.62
2.13
446.49
20,961.97%
Other Current Assets
19.96
38.70
-18.74
-48.42%
Short Term Loans and Advances
30.34
63.26
-32.92
-52.04%
Total Current Assets
1,739.93
2,649.36
-909.43
-34.33%
Net Current Assets (Including Current Investments)
758.12
2,141.32
-1,383.20
-64.60%
Total Current Assets Excluding Current Investments
1,739.93
1,868.98
-129.05
-6.90%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
1,951.30
3,982.90
-2,031.60
-51.01%
Contingent Liabilities
121.23
4.82
116.41
2,415.15%
Total Debt
0.00
0.00
0.00
0.00%
Book Value per share (adjusted)
349.12
271.49
77.63
28.59%
Annual - Borrowings
No Borrowings in the last few periods
No Borrowings in the last few periods;
Annual - Other Long Term Liabilities
Other Long Term Liabilities 118.67 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 208.63% vs 1,283.09% in Mar 2025
Annual - Fixed Assets
Fixed Assets 4.67 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is -83.64% vs -54.52% in Mar 2025
Annual - Investments
No Investments in the last few periods
No Investments in the last few periods;
Annual - Current Assets
Current Assets 1,739.93 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 29.62% vs 43.92% in Mar 2025
Footer loading
